Best-in-Class Treatment for DDD
Notogen presents a unique opportunity to invest in the expansive spine, orthopedic and sports medicine therapeutic technology space. A profound void exists in the continuum of care related to non-surgical intervention for back pain. NTG-101 is positioned to address this void with a simple, cost-effective solution. Notogen has secured investment to achieve near-term goals and is currently seeking additional investment to support future milestones.
Events & Presentations
2018 Biologic: Interventions for Spinal Pathologies: Stem Cells, Growth Factors & Novel Therapeutics
North American Spine Society (NASS) 33rd Annual Meeting
LLC 5th Annual Ehlers-Danlos & Chronic Pain Conference
North American Spine Society (NASS) Conference 2017
North American Spine Society (NASS) Conference 2016